Repligen (RGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The first quarter of 2026 began with optimism ...

The stock price of Repligen (NASDAQ: RGEN), a U.S.-based life sciences company involved in production of materials used in the manufacture of biological drugs, has seen a 12% drop over the last twenty ...

Repligen Corp(纳斯达克股票代码:RGEN)首席执行官Olivier Loeillot近期出售了大量公司普通股。 2026年4月21日,Loeillot先生处置了3,832股Repligen普通股。这些股票以每股$140.00的价格出售,交易总额达到$536,480。此次出售是根据Loeillot先生于2025年8月19日采用的预先安排的10b5-1交易计划执行的。此次出售之际,Rep ...

AI capability is advancing fast. In some domains, it is solving problems that were out of reach just a few years ago. But ...

Repligen Corporation's stock continues to track lower within its longer-term downtrend. Shares trade at 88x forward earnings, Q2 numbers were flat, and FY'23 guidance has been narrowed due to flat ...

View Repligen Corporation RGEN stock quote prices, financial information, real-time forecasts, and company news from CNN.